MELBOURNE, Australia and MENLO PARK, Calif., Dec. 11 /PRNewswire- FirstCall/ -- ChemGenex Pharmaceuticals Limited (ASX: CXS - News; Nasdaq: CXSP - News) announced today that two abstracts related to the clinical development of Ceflatonin? (homoharringtonine, or "HHT"), its experimental drug for the treatment of certain leukemias, have been published in the November 16, 2005 issue of Blood (Volume 106, Issue 11), the journal of the American Society of Hematology (ASH). The abstracts, which were prepared by investigators from the University of Texas M.D. Anderson Cancer Center, are available on the ASH website, www.hematology.org.
http://cmlsupport.blogspot.com/2005/12/chemgenex-reports-compelling-phase-2.html
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com
Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com
CML (Chronic Myelogenous Leukemia Support List)
---------------------------------
Part Of CMLHope.Com
An International Community Of CML Patients
For more information: http://cmlhope.com
Post Message: [email protected]
Subscribe: [EMAIL PROTECTED]
Unsubscribe: [EMAIL PROTECTED]
Change To No Mail/Web: [EMAIL PROTECTED]
Change To Digest: [EMAIL PROTECTED]
Change To Email: [EMAIL PROTECTED]
List Help: [EMAIL PROTECTED]
CML Group Web Site http://groups.yahoo.com/group/CML
YAHOO! GROUPS LINKS
- Visit your group "CML" on the web.
- To unsubscribe from this group, send an email to:
[EMAIL PROTECTED]
- Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.
